Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
7.22
-0.90 (-11.08%)
Nov 18, 2024, 3:07 PM EST - Market open
Camp4 Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -49.71 | -49.29 | -44.19 |
| Depreciation & Amortization | 1.73 | 1.68 | 0.88 |
| Stock-Based Compensation | 3 | 2.91 | 1.38 |
| Other Operating Activities | 1.74 | 1.82 | 1.69 |
| Change in Accounts Payable | 0.24 | -1.12 | 1.33 |
| Change in Other Net Operating Assets | 0.09 | -0.15 | 0.37 |
| Operating Cash Flow | -42.92 | -44.16 | -38.54 |
| Capital Expenditures | -0.63 | -0.68 | -4.03 |
| Investing Cash Flow | -0.63 | -0.68 | -4.03 |
| Long-Term Debt Issued | - | 0.71 | - |
| Long-Term Debt Repaid | - | -0.59 | -0.09 |
| Net Debt Issued (Repaid) | -0.85 | 0.12 | -0.09 |
| Issuance of Common Stock | 0.18 | 0.19 | 0.06 |
| Financing Cash Flow | -1.28 | 0.3 | 100.16 |
| Net Cash Flow | -44.83 | -44.53 | 57.59 |
| Free Cash Flow | -43.55 | -44.83 | -42.57 |
| Free Cash Flow Margin | -12441.71% | -12809.43% | - |
| Free Cash Flow Per Share | -97.75 | -113.51 | -136.31 |
| Levered Free Cash Flow | - | -30.16 | - |
| Unlevered Free Cash Flow | - | -30.16 | - |
| Change in Net Working Capital | - | 1.65 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.